We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Next Generation Automation Solution Exhibited at AACC

By Christina Chang, LabMedica Regional Director
Posted on 15 Jul 2013
Print article
AACC 2012: A new, adaptable automation solution allows a phased implementation to accommodate both current and future needs of medium- to very high-volume laboratories. The solution was unveiled at the 2012 annual meeting of the AACC and ASCLS and Clinical Lab Expo in Los Angeles (CA, USA) on July 15–19, 2012.

The circular track and modular design ensure Siemens Aptio Automation solution can adapt to nearly any lab or testing environment. It also offers connectivity to Siemens’ (Munich, Germany) portfolio of automation-ready analyzers, facilitating a multidisciplinary approach to testing. In addition, Aptio Automation’s point-in-space aspiration feature helps workflow by reducing the need to aliquot samples, and its puck-based system with Radio-frequency identification (RFID) enables individual sample routing and tracking, along with STAT prioritization.

William Bartlett, PhD, Joint Clinical Director of Diagnostics at the UK’s NHS Tayside (Dundee, United Kingdom) one of the first laboratories to deploy Aptio Automation, said: “We chose Aptio Automation because it can handle increasing workloads while enabling us to use our staff better. We expect that the implementation of this new platform will allow us to provide a state-of-the-art service that aligns the lab function with Tayside’s overall goals for organizational sustainability and improved patient outcomes.”

Today clinical laboratories are turning to automation to help them meet the growing demand for in vitro diagnostic testing as the labor force declines. And, these trends are only expected to continue, as approximately 17 % of laboratory professionals are anticipated to retire in the next five years. Aptio Automation is an adaptable solution that allows for a phased implementation to accommodate both current and future needs of labs.

Related Links:
Siemens
NHS Tayside


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more